UBS AM’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-62,355
| Closed | -$297K | – | 2666 |
|
2023
Q2 | $297K | Hold |
62,355
| – | – | ﹤0.01% | 2480 |
|
2023
Q1 | $297K | Sell |
62,355
-127,830
| -67% | -$610K | ﹤0.01% | 2480 |
|
2022
Q4 | $1.65M | Buy |
190,185
+11,901
| +7% | +$104K | ﹤0.01% | 1616 |
|
2022
Q3 | $2.12M | Sell |
178,284
-5,157
| -3% | -$61.4K | ﹤0.01% | 1566 |
|
2022
Q2 | $2.61M | Buy |
183,441
+13,457
| +8% | +$192K | ﹤0.01% | 1508 |
|
2022
Q1 | $3.54M | Sell |
169,984
-12,934
| -7% | -$269K | ﹤0.01% | 1507 |
|
2021
Q4 | $4.23M | Sell |
182,918
-3,244
| -2% | -$74.9K | ﹤0.01% | 1500 |
|
2021
Q3 | $5.55M | Sell |
186,162
-5,475
| -3% | -$163K | ﹤0.01% | 1311 |
|
2021
Q2 | $6.55M | Sell |
191,637
-2,091
| -1% | -$71.4K | ﹤0.01% | 1262 |
|
2021
Q1 | $6.37M | Sell |
193,728
-1,097
| -0.6% | -$36.1K | ﹤0.01% | 1238 |
|
2020
Q4 | $12M | Sell |
194,825
-155,175
| -44% | -$9.54M | 0.01% | 994 |
|
2020
Q3 | $12.4M | Buy |
+350,000
| New | +$12.4M | 0.01% | 881 |
|